vcfirmsdirectory.com

SEC exempt reporting adviser · Early stage

CKG MANAGEMENT

CKG Management administers documentation for collective private investments by accredited investors, focused on early-stage biotech and pharma companies. It also offers advisory and fractional CFO/COO services.

Registered · United States
New investments · 12 months
Fund vehiclesPublic
7
7 active · US private fund
First cheque
Active portfolio
FreeRegistry entries, fund vehicles and filingsPROEverything we enrich: deals, team, events and signals
Updated 8 Nov 2026, 05:38 CETSources: ckgus.com · SEC adviser filings

Investment activity

Round-by-round activity is part of PRO

See every round CKG MANAGEMENT joined

Monthly deal flow, follow-ons, fund closes and exits.

Key signal this week

See all signals

Is CKG MANAGEMENT right for your round?

Is CKG MANAGEMENT a fit for your round?

Match your sector, round, size and region against where they invest, and see who to approach.

Key stats

Fund vehiclesPublic
7
7 active · US private fund
SEC adviser filings
First cheque
Core stage
New deals per year
Lead rate
Active portfolio
Exits

Fund cycle Public record

Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.

R4JV, LLCUS private fund · Active · United States · $11.3M gross assets · filed 14 May 2026
NT3JV, LLCUS private fund · Active · United States · $3M gross assets · filed 14 May 2026
R2JV, LLCUS private fund · Active · United States · $3M gross assets · filed 14 May 2026
NTJV, LLCUS private fund · Active · United States · $2M gross assets · filed 14 May 2026
NT2JV, LLCUS private fund · Active · United States · $1.4M gross assets · filed 14 May 2026
R3JV, LLCUS private fund · Active · United States · $377K gross assets · filed 14 May 2026
C2JV, LLCUS private fund · Active · United States · $80K gross assets · filed 14 May 2026
Deployed (new cheques)
Next fund expected

Latest investments

Rounds CKG MANAGEMENT joined, from press and the firm’s own posts.

DateCompanyRoundRound sizeRoleAlongside

Every round CKG MANAGEMENT joined

Round sizes, CKG MANAGEMENT’s role and who invested alongside.

Round-by-round history is part of PRO

Notable portfolio

CAGE BioNanoscope TherapeuticsOncoNano MedicineRenibus Therapeutics

Portfolio and exits

Every company CKG MANAGEMENT backed and how the exits played out.

Where the money goes

Share of companies at first investment, from the rounds we track.

Where CKG MANAGEMENT puts its money

Sector, country and stage mix across every first cheque.

Investment team

The investment team

Partners, principals and investors, with their city, focus and how to reach them.

Where to meet CKG MANAGEMENT

Events where CKG MANAGEMENT’s team spoke or showed up, from event programmes, press and the firm’s own posts.

Where to meet CKG MANAGEMENT’s partners

The events they speak at, your next chance to meet them, and which ones founders can get into.

Signals

Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.

14 May 2026Fund filingForm ADV filed by CKG MANAGEMENT: 7 private funds, $21.2M in gross assets.SEC Form ADV · public record

Founders also look at

Frequently asked questions

CKG MANAGEMENT is based in the United States.

7 fund vehicles are on public registers (SEC adviser filings), including R4JV, LLC, NT3JV, LLC and R2JV, LLC.

Stages: Early stage. Sectors: Biotech. From the firm’s own website.

CKG MANAGEMENT lists 4 portfolio companies on its website: CAGE Bio, Nanoscope Therapeutics, OncoNano Medicine and Renibus Therapeutics.

Firms whose websites list some of the same companies include Bios Partners.

Know before CKG MANAGEMENT’s next round is announced.

PRO tracks CKG MANAGEMENT’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.

CKG MANAGEMENTGet CKG MANAGEMENT’s signals the day they landMonitor

Search the directory

Type a firm's name, a city or a country.